European Archives - Page 849 of 1452 - European Medical Journal

New Advances in the Treatment of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy

Both spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are monogenic neuromuscular diseases, which cause progressive proximal-to-distal muscular weakness, leading to loss of motor function and related pulmonary and musculoskeletal co-morbidities and reduced survival.

UEG Week Virtual 2021 Janssen-Sponsored Virtual Satellite Symposium: “Targeting IL-12/23 in ulcerative colitis: from evidence to bedside”

This podcast reviews the Janssen-Sponsored Virtual Satellite Symposium titled “Targeting IL-12/23 in ulcerative colitis: from evidence to bedside”…

Flagellate Erythema: A Case of Shiitake Dermatitis and Review of Pathogenesis

Shiitake dermatitis is a rare eruption that is associated with the ingestion of uncooked shiitake mushrooms, resulting in a distinctive…

Atorvastatin, Aspirin, and Hydroxyurea Treating Polycythaemia Vera

The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…

Outlining the 2021 ESC Guidelines for the Management of Valvular Heart Disease

Outlining the 2021 ESC Guidelines for the Management of Valvular Heart Disease

Valvular heart disease (VHD) is a common condition characterised by damage or a defect in one or more of the four heart valves…

Prescribing Aspirin Based on the Benefit-to-Risk Ratio

The American Heart Association and American College of Cardiology have restricted the use of aspirin in cardiovascular disease prevention to people under 70…

Identifying Patients with Graves’ Disease at High-Risk for Atrial Fibrillation

Hyperthyroidism is associated with atrial fibrillation and heart failure, two conditions that can cause morbidity and mortality…

What Hurts One, Hurts All

Jonathan and Dr Rola Hallam assess the harrowing issues of health disparity across the globe, Rola’s experiences providing aid in Syria, and what we all…

EMJ Oncology 10 [Supplement 1] 2022

This symposium review looks at the devastating global impact of lung cancer, a disease that claimed almost 2 million lives in 2020. Despite recent advances in research and the development of innovative therapies available to patients, lung cancer remains the world’s leading cause of cancer-related morbidity and mortality.

Increasing Therapy Options in Solid Tumours: A Consideration of Testing Methodologies in Non-small Cell Lung Cancer and Breast Cancer

Lung cancer has a devastating global impact, claiming almost 2 million lives in 2020.1 Despite advances in treatment, lung cancer remains the world’s leading cause of cancer-related morbidity and mortality.